SMOC2 and arthritic joint disease: Ad-shRNA-SMOC2 treatment caused significant reductions in paw swelling, arthritis scores, hind paw volumes and ankle circumferences in CIA rats compared with those of CIA rats treated with the control shRNA vector (Fig. 7B–E).